+Search query
-Structure paper
Title | Rivastigmine and metabolite analogues with putative Alzheimer's disease-modifying properties in a Caenorhabditis elegans model |
---|---|
Journal, issue, pages | Commun Chem, Year 2019 |
Publish date | Oct 30, 2017 (structure data deposition date) |
![]() | Dighe, S. / De la Mora, E. / Chan, S. / Kantham, S. / McColl, G. / Veliyath, S.K. / Miles, J.A. / Nessar, Z.Y. / Mcgeary, R. / Silman, I. ...Dighe, S. / De la Mora, E. / Chan, S. / Kantham, S. / McColl, G. / Veliyath, S.K. / Miles, J.A. / Nessar, Z.Y. / Mcgeary, R. / Silman, I. / Weik, I. / Parat, M.O. / Brazzolotto, X. / Ross, B. |
![]() | ![]() |
Methods | X-ray diffraction |
Resolution | 2 - 2.6 Å |
Structure data | ![]() PDB-6eue: ![]() PDB-6eyf: |
Chemicals | ![]() ChemComp-1PE: ![]() ChemComp-NAG: ![]() ChemComp-HOH: ![]() ChemComp-BY2: ![]() ChemComp-GOL: ![]() ChemComp-SO4: |
Source |
|
![]() | HYDROLASE / Cholinesterase / alzheimer disease / organophosphate / carbamylated / Butyrylcholinesterase / rivastigmine analogue / rational design |